UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −24)

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for

the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28

U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2020). Since that time, 189 additional action(s) have been

transferred to the Southern District of Florida. With the consent of that court, all such actions have

been assigned to the Honorable Robin L. Rosenberg.

It appears that the action(s) on this conditional transfer order involve questions of fact that are

common to the actions previously transferred to the Southern District of Florida and assigned to

Judge Rosenberg.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict

Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the

Southern District of Florida for the reasons stated in the order of February 6, 2020, and, with the

consent of that court, assigned to the Honorable Robin L. Rosenberg.

This order does not become effective until it is filed in the Office of the Clerk of the United States

District Court for the Southern District of Florida. The transmittal of this order to said Clerk shall be

stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the

Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

John W. Nichols

Clerk of the Panel

Case MDL No. 2924 Document 369 Filed 07/02/20 Page 1 of 2

Case 9:20-md-02924-RLR Document 1033 Entered on FLSD Docket 07/02/2020 Page 1 of 2

Jul 02, 2020 Maria Cruz Jul 2, 2020

Case 9:20-cv-81074-RLR Document 21 Entered on FLSD Docket 07/06/2020 Page 1 of 2
IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

SCHEDULE CTO−24 − TAG−ALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

CALIFORNIA NORTHERN

CAN 3 20−03913 Dudley v. GlaxoSmithKline LLC et al

CAN 3 20−03914 Goetz v. GlaxoSmithKline, LLC et al

CAN 3 20−03921 Cash v. GlaxoSmithKline, LLC et al

CAN 3 20−03931 Brittner v. GlaxoSmithKline, LLC et al

CAN 3 20−03946 Ortega v. GlaxoSmithKline, LLC et al

CAN 3 20−03948 Campbell v. GlaxoSmithKline, LLC et al

CAN 3 20−03959 Flores v. GlaxoSmithKline, LLC et al

CAN 3 20−03961 Astruc v. GlaxoSmithKline, LLC et al

CAN 3 20−03963 Brodie v. GlaxoSmithKline, LLC et al

CAN 3 20−03969 Harbaugh v. GlaxoSmithKline, LLC et al

CAN 3 20−03970 Reynolds v. GlaxoSmithKline, LLC et al

CAN 3 20−03972 Gregory v. GlaxoSmithKline, LLC et al

CAN 3 20−03973 Williams v. GlaxoSmithKline, LLC et al

CAN 3 20−03974 Hernandez v. GlaxoSmithKline, LLC et al

CAN 3 20−03978 Geurin v. GlaxoSmithKline, LLC et al

CAN 3 20−03980 Carbajal v. GlaxoSmithKline, LLC et al

CAN 4 20−03918 John Russell v. GlaxoSmithKline, LLC et al

CAN 4 20−03924 Salvatore v. GlaxoSmithKline, LLC et al

CAN 4 20−03954 White v. GlaxoSmithKline LLC et al

CAN 4 20−03968 Gigliello v. GlaxoSmithKline, LLC et al

Case MDL No. 2924 Document 369 Filed 07/02/20 Page 2 of 2

Case 9:20-md-02924-RLR Document 1033 Entered on FLSD Docket 07/02/2020 Page 2 of 2

Case 9:20-cv-81074-RLR Document 21 Entered on FLSD Docket 07/06/2020 Page 2 of 2